New program aims to ease lymphoma Survivors' fear of recurrence

NCT ID NCT05080166

Completed Symptom relief Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 05, 2026 · Updated 3 times

Summary

This study tests a program called UPLYFT designed to help lymphoma survivors who have finished treatment cope with the fear that their cancer might return. The program provides information and tools to improve quality of life and reduce worry. Researchers will first gather feedback from clinicians and then test the program with about 74 survivors to see if it is feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) - a behavioral intervention
What this could lead to: If successful, this could provide a structured program to help lymphoma survivors cope with fear of cancer returning and improve their daily well-being.
What could go wrong: This is a very early pilot study with only 74 participants, focused on feasibility and feedback. It is not designed to prove the program works, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHOMA SURVIVORSHIP

Contacts and locations

Locations

Dana-Farber Cancer Institute

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.